NCT05981547View on ClinicalTrials.gov

Patterns and Glycaemic Endpoints for Diagnosing Gestational Diabetes

RecruitingOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

November 22, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

November 30, 2025

Conditions

Gestational Diabetes

Interventions

DEVICE

Libre 3 continuous glucose monitoring sensor

Libre 3 CGM sensor applied to women prior to their Oral Glucose Tolerance test.

Trial Locations (1)

Unknown

RECRUITING

Portsmouth Hospitals University NHS Trust, Portsmouth

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Abbott

INDUSTRY

lead

Portsmouth Hospitals NHS Trust

OTHER_GOV